These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
250 related articles for article (PubMed ID: 27636161)
1. Enhanced Antiglioblastoma Efficacy of Neovasculature and Glioma Cells Dual Targeted Nanoparticles. Lv L; Jiang Y; Liu X; Wang B; Lv W; Zhao Y; Shi H; Hu Q; Xin H; Xu Q; Gu Z Mol Pharm; 2016 Oct; 13(10):3506-3517. PubMed ID: 27636161 [TBL] [Abstract][Full Text] [Related]
2. Improved anti-glioblastoma efficacy by IL-13Rα2 mediated copolymer nanoparticles loaded with paclitaxel. Wang B; Lv L; Wang Z; Jiang Y; Lv W; Liu X; Wang Z; Zhao Y; Xin H; Xu Q Sci Rep; 2015 Nov; 5():16589. PubMed ID: 26567528 [TBL] [Abstract][Full Text] [Related]
3. PEG-PLA nanoparticles modified with APTEDB peptide for enhanced anti-angiogenic and anti-glioma therapy. Gu G; Hu Q; Feng X; Gao X; Menglin J; Kang T; Jiang D; Song Q; Chen H; Chen J Biomaterials; 2014 Sep; 35(28):8215-26. PubMed ID: 24974009 [TBL] [Abstract][Full Text] [Related]
4. PEGylated poly(trimethylene carbonate) nanoparticles loaded with paclitaxel for the treatment of advanced glioma: in vitro and in vivo evaluation. Jiang X; Xin H; Sha X; Gu J; Jiang Y; Law K; Chen Y; Chen L; Wang X; Fang X Int J Pharm; 2011 Nov; 420(2):385-94. PubMed ID: 21920419 [TBL] [Abstract][Full Text] [Related]
6. Nanoparticle-mediated drug delivery to tumor neovasculature to combat P-gp expressing multidrug resistant cancer. Bai F; Wang C; Lu Q; Zhao M; Ban FQ; Yu DH; Guan YY; Luan X; Liu YR; Chen HZ; Fang C Biomaterials; 2013 Aug; 34(26):6163-74. PubMed ID: 23706689 [TBL] [Abstract][Full Text] [Related]
7. Synergistic targeting tenascin C and neuropilin-1 for specific penetration of nanoparticles for anti-glioblastoma treatment. Kang T; Zhu Q; Jiang D; Feng X; Feng J; Jiang T; Yao J; Jing Y; Song Q; Jiang X; Gao X; Chen J Biomaterials; 2016 Sep; 101():60-75. PubMed ID: 27267628 [TBL] [Abstract][Full Text] [Related]
8. Peptide-conjugated biodegradable nanoparticles as a carrier to target paclitaxel to tumor neovasculature. Yu DH; Lu Q; Xie J; Fang C; Chen HZ Biomaterials; 2010 Mar; 31(8):2278-92. PubMed ID: 20053444 [TBL] [Abstract][Full Text] [Related]
9. CGKRK-modified nanoparticles for dual-targeting drug delivery to tumor cells and angiogenic blood vessels. Hu Q; Gao X; Kang T; Feng X; Jiang D; Tu Y; Song Q; Yao L; Jiang X; Chen H; Chen J Biomaterials; 2013 Dec; 34(37):9496-508. PubMed ID: 24054848 [TBL] [Abstract][Full Text] [Related]
17. The influence of the penetrating peptide iRGD on the effect of paclitaxel-loaded MT1-AF7p-conjugated nanoparticles on glioma cells. Gu G; Gao X; Hu Q; Kang T; Liu Z; Jiang M; Miao D; Song Q; Yao L; Tu Y; Pang Z; Chen H; Jiang X; Chen J Biomaterials; 2013 Jul; 34(21):5138-48. PubMed ID: 23582684 [TBL] [Abstract][Full Text] [Related]
18. Free paclitaxel loaded PEGylated-paclitaxel nanoparticles: preparation and comparison with other paclitaxel systems in vitro and in vivo. Lu J; Chuan X; Zhang H; Dai W; Wang X; Wang X; Zhang Q Int J Pharm; 2014 Aug; 471(1-2):525-35. PubMed ID: 24858391 [TBL] [Abstract][Full Text] [Related]
19. Aptamer-functionalized PEG-PLGA nanoparticles for enhanced anti-glioma drug delivery. Guo J; Gao X; Su L; Xia H; Gu G; Pang Z; Jiang X; Yao L; Chen J; Chen H Biomaterials; 2011 Nov; 32(31):8010-20. PubMed ID: 21788069 [TBL] [Abstract][Full Text] [Related]
20. Co-administration of dual-targeting nanoparticles with penetration enhancement peptide for antiglioblastoma therapy. Miao D; Jiang M; Liu Z; Gu G; Hu Q; Kang T; Song Q; Yao L; Li W; Gao X; Sun M; Chen J Mol Pharm; 2014 Jan; 11(1):90-101. PubMed ID: 24295590 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]